Form 4: Natera Executive Sells Shares for Tax Obligations

Solomon Moshkevich, Natera's President of Clinical Diagnostics, sold common stock totaling 23,498 shares to cover tax withholding obligations from vested Restricted Stock Units.

Summary

• Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), reported sales of common stock.
• On January 20, 2026, 23,205 shares were sold at an average price of $234.7384 per share.
• On January 21, 2026, an additional 293 shares were sold at an average price of $235 per share.
• These sales were executed to satisfy tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
• The transactions were conducted pursuant to a Rule 10b5-1(c) written plan, indicating pre-planned sales.
• Following these transactions, Solomon Moshkevich beneficially owns 144,699 shares of Natera common stock.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions for tax withholding purposes related to RSU vesting, which is a neutral event for the company's operational or financial performance. It does not indicate positive or negative sentiment regarding the company's prospects.

Positives

• The sales were made to cover tax obligations from vested Restricted Stock Units, indicating that RSUs previously granted to the executive have vested, which is a form of compensation.
• The transactions were executed under a Rule 10b5-1(c) plan, suggesting pre-planned sales rather than discretionary selling based on new material non-public information.

Negatives

• The sale of shares by an insider, even for tax purposes, reduces their direct ownership stake in the company.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the routine nature of insider transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine event for publicly traded companies, where executives often sell shares to cover tax obligations upon the vesting of equity awards. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal direct impact, as these are routine tax-related sales under a pre-arranged plan and do not reflect a change in the executive's confidence in the company. The total number of shares sold is a small fraction of the company's outstanding shares.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Keywords

Natera, NTRA, Form 4, Insider Trading, Stock Sale, RSU Vesting, Tax Withholding, Solomon Moshkevich, Rule 10b5-1